Taurine/(Creatine and Phosphocreatine) ratio
|
Basic information |
| Metabolite name | Taurine/(Creatine and Phosphocreatine) ratio |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | Taurine/(Creatine and Phosphocreatine) ratio |
| N/A |
|
N/A |
|
N/A |
| Synonyms | NA |
| No. of studies | 6 |
|
Relationship between Taurine/(Creatine and Phosphocreatine) ratio and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M292 | Type1 | cLH group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M292 | Type2 | cLH + ECS group vs. cLH group | Hippocampus | Sprague-Dawley rat | Down |
| Study M294 | Type1 | CMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M352 | Type1 | depression group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M352 | Type1 | depression group vs. control group | Frontal cortex | Sprague-Dawley rat | Up |
| Study M521 | Type1 | CUMS group vs. control group | Hippocampus | Wistar rat | Down |
| Study M537 | Type1 | experimental autoimmune prostatitis group vs. control group | Hippocampus | NOD/ShiLtJ mouse | Up |
| Study M733 | Type3 | fluoxetine group vs. control group, day 1 | Medial prefrontal cortex | Sprague-Dawley rat | Down |